C. Andrew Kistler, MD, PharmD

Andy authors Cancer Therapy Advisor's "In the Clinic" column. He is a gastroenterologist with interests in GI oncology, immunotherapy, the gut microbiome, and clinical pharmacology.

All articles by C. Andrew Kistler, MD, PharmD

Gastrointestinal Cancer

Celiac Disease and Small Bowel Cancers: A Question of Risk

C. Andrew Kistler, MD, PharmD

January 8, 2021

Despite numerous studies showing a potential association between celiac disease and small bowel cancer, there is a lack of data evaluating the risk of specific subtypes of small bowel cancer.

There was a small beneficial effect of adding docetaxel to androgen suppression and radiotherapy, a follow-up study showed.

Prostate Cancer

Docetaxel Use in High-Risk Prostate Cancer: New Long-Term Data

C. Andrew Kistler, MD, PharmD

March 18, 2020

There was a small beneficial effect of adding docetaxel to androgen suppression and radiotherapy, a follow-up study showed.

Prostate Cancer

MRI-Guided Transurethral Ultrasound Ablation: Promising Data in Prostate Cancer

C. Andrew Kistler, MD, PharmD

January 17, 2020

MRI-guided TULSA uses a transurethral catheter to precisely apply ultrasound and MRI-guided thermotherapy to ablate cancerous tissue within the prostate gland.

Next post in Prostate Cancer

C. Andrew Kistler, MD, PharmD

All articles by C. Andrew Kistler, MD, PharmD

Celiac Disease and Small Bowel Cancers: A Question of Risk

Docetaxel Use in High-Risk Prostate Cancer: New Long-Term Data

MRI-Guided Transurethral Ultrasound Ablation: Promising Data in Prostate Cancer

Risk-Based Approach Could Help Target Prostate Cancer Screening